The clinical-stage biopharmaceutical company reported that the trial met its primary endpoint, with up to 59.1% of participants achieving MASH resolution without worsening of fibrosis in an ...

The U.S. dollar is on course for its worst first half year since 1973, as it plummeted again on Thursday amid rising expectations for Federal Reserve easing and statements from President Donald Trump ...

Investing.com - McCormick & Company (NYSE: MKC) has reported better-than-anticipated profit in its fiscal second quarter and ...

Toronto’s commodity-heavy S&P/TSX composite index pulled back on Wednesday from a record high, as the market cooled. The index has been shielded from some of the volatility that has impacted Wall ...

The company also noted that its statement falls under Rule 2.8 of the UK regulatory code, which now prohibits Shell from making an offer for BP for the next six months. This restriction means Shell ...

Investing.com -- Iran’s Guardian Council has ratified a parliamentary bill that will suspend the country’s cooperation with the International Atomic Energy Agency (IAEA), according to a Thursday ...

European leaders are widely backing a quick trade deal with the United States as the expiration of a delay to President ...

Associated British Foods (OTC:ASBFY) said on Thursday that its bioethanol unit, Vivergo, remains under threat due to ...

Investing.com - The impact of sweeping U.S. tariffs is expected to ripple through the world economy in the second half of ...

UBS Global Research has downgraded British Land (LON: BLND) to “neutral” from “buy,” citing downside risks to fiscal 2026 earnings and weaker-than-expecte ...

The deadlock marks a sharp shift from earlier optimism, following Trump’s claim that New Delhi had proposed a "no tariffs" agreement for American goods, and officials from both sides suggesting India ...

Goldman Sachs (NYSE: GS) has upgraded Entain (LON: ENT) to "buy," citing improved risk/reward dynamics supported by momentum in both its online business and BetMG ...